Syncardia Systems LLC - Strategic SWOT Analysis Review

Syncardia Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description - A detailed description of the company’s operations and business divisions.
• Corporate strategy - The publisher's summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Syncardia Systems LLC (SynCardia), a subsidiary of Picard Medical Inc, develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart (TAH) temporarily takes up the complete function of a failed human heart in patients suffering from final stage biventricular heart failure (BHF) before receiving a successful heart transplant. The TAH replaces the ventricles and four heart valves of a failing heart and eliminates the symptoms and source of end-stage BHF. SynCardia also offers the external pneumatic drivers, which power TAH and facilitate the discharge of clinically stable patients from the hospital, while waiting for a matching donor heart. The company also offers TAH through certified centers in various parts of Europe, North America and Asia-Pacific. It operates through subsidiary in Germany. SynCardia is headquartered in Tucson, Arizona, the US.

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.